P/E ratio for Dynavax Technologies (DVAX)
P/E ratio as of April 2024 (TTM): 13.0
According to Dynavax Technologies 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 13.0345. At the end of 2022 the company had a P/E ratio of 4.61.
P/E ratio history for Dynavax Technologies from 2004 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 4.61 | -80.03% |
| 2021 | 23.1 | -504.3% |
| 2020 | -5.71 | 120.43% |
| 2019 | -2.59 | -27.87% |
| 2018 | -3.59 | -64.69% |
| 2017 | -10.2 | 648.72% |
| 2016 | -1.36 | -81.52% |
| 2015 | -7.34 | 50.27% |
| 2014 | -4.89 | -4.5% |
| 2013 | -5.12 | -26.38% |
| 2012 | -6.95 | -18.34% |
| 2011 | -8.51 | 83.56% |
| 2010 | -4.64 | 148.21% |
| 2009 | -1.87 | 15.66% |
| 2008 | -1.62 | -52.27% |
| 2007 | -3.38 | -40.65% |
| 2006 | -5.70 | 5.64% |
| 2005 | -5.40 | -42.65% |
| 2004 | -9.41 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 13.7 | 4.73% | 🇺🇸 USA |
 Amgen AMGN | 18.6 | 42.46% | 🇺🇸 USA |
 Biogen BIIB | 10.3 | -20.82% | 🇺🇸 USA |
 Gilead Sciences GILD | 15.1 | 15.62% | 🇺🇸 USA |
 Merck MRK | 68.7 | 427.40% | 🇺🇸 USA |
 AstraZeneca AZN | 34.4 | 164.21% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 11.2 | -13.94% | 🇬🇧 UK |
 Agenus
AGEN | -5.85 | -144.86% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -6.39 | -149.02% | 🇮🇱 Israel |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.